AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

Recruitingn/aAges 1 Year - anyAllUniversity of Milano Bicocca
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown. This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * All AIH patients living in Italy and aged at least 1 year can be included in the database. * Willing and able to give informed consent prior to any study specific procedure being * Diagnosis of AIH according to the most recent published guidelines (EASL) Exclusion Criteria: * Subject unwilling to participate at the study
๐Ÿ’Š

What it tests

  • Clinical Information
๐Ÿ“

Where

1 site
Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy